SWEDENCARE AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64.4 SEK | +1.50% |
|
+7.24% | +5.64% |
| 11:06am | New Symrise CEO wants to drive profitability | DP |
| 03/06 | Wihlborgs Fastigheter Signs New Lease at Swedish Property | MT |
| Sales 2024 * | 265.94Cr 25Cr 2.12TCr | Sales 2025 * | 299.98Cr 29Cr 2.39TCr | Capitalization | 1.01TCr 96Cr 8.04TCr |
|---|---|---|---|---|---|
| Net income 2024 * | 23Cr 2.18Cr 181.97Cr | Net income 2025 * | 34Cr 3.28Cr 273.76Cr | EV / Sales 2024 * | 4.16 x |
| Net Debt 2024 * | 100.05Cr 9.56Cr 798.52Cr | Net Debt 2025 * | 49Cr 4.66Cr 389.45Cr | EV / Sales 2025 * | 3.52 x |
| P/E ratio 2024 * |
44.2
x | P/E ratio 2025 * |
29.4
x | Employees | 552 |
| Yield 2024 * |
0.79% | Yield 2025 * |
1.26% | Free-Float | 30.45% |
More Fundamentals
* Assessed data
More news
Latest transcript on Swedencare AB
More press releases
| 1 day | -0.55% | ||
| 1 week | +5.08% | ||
| Current month | +6.59% | ||
| 1 month | +14.73% | ||
| 3 months | +4.30% | ||
| 6 months | -0.09% | ||
| Current year | +3.51% |
1 week
59.30
63.95
1 month
53.7063.95
Current year
52.1069.12
1 year
32.5669.12
3 years
22.90159.00
5 years
11.60159.00
10 years
2.80159.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/14/01 | |
Jenny Graflind
DFI | Director of Finance/CFO | 48 | 01/17/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 01/23/01 | |
| Director/Board Member | 57 | 01/16/01 | |
| Director/Board Member | 61 | 01/19/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 775 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/24/12 | 64.4 | +1.50% | 106 613 |
| 11/24/11 | 63.45 | +1.44% | 81,329 |
| 10/24/10 | 62.55 | +1.05% | 102,015 |
| 07/24/07 | 61.9 | +3.08% | 113,882 |
| 05/24/05 | 60.05 | +1.26% | 78,221 |
Delayed Quote Nasdaq Stockholm, June 12, 2024 at 04:00 pm IST
More quotes
Swedencare publ AB is a Sweden-based company, which is mainly involved in the veterinary supplies industry. The Company operates as a provider of various products for animal health, distributed to veterinarians, pet stores and pharmacies. It operates through four subsidiaries, namely SDC Distribution for Scandinavian countries, Buccosante located in France, Informpet in the United Kingdom and SwedencareUSA in the United States. The Company's product portfolio includes ProDen product family, which consists of ProDen PlaqueOff Teeth and Gums, ProDen PlaqueOff Powder, ProDen PlaqueOff Powder Cat and ProDen PlaqueOff Dental Bites, among others. The products are available at veterinary clinics, pet retailers, pharmacies, health stores and dentist practices.
Sector
Pharmaceuticals
Calendar
25/07/2024
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
63.45
SEK
Average target price
67
SEK
Spread / Average Target
+5.59%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +3.51% | 96Cr | |
| -9.54% | 8.15TCr | |
| +23.15% | 906.82Cr | |
| +24.12% | 367.44Cr | |
| -1.67% | 317.35Cr | |
| +17.23% | 172.66Cr | |
| -1.76% | 130.22Cr | |
| -26.74% | 121.6Cr | |
| -29.68% | 117.5Cr | |
| -22.72% | 100.98Cr |
- Stock Market
- Equities
- SECARE Stock
